哌拉西林他唑巴坦致严重血小板减少一例并文献复习

经验交流

季春莲¹^,^†(

), 庞丽莎¹, 孟建标¹

全文 ( ) 下载PDF ( ) 导出引用

1	LeviM.Platelets in critical illness[J].Semin Thromb Hemost,2016,42 (3):252-257.
2	宋景春, 刘树元, 朱峰, 等. 中国成人重症患者血小板减少诊疗专家共识[J]. 解放军医学杂志, 2020, 45 (5) : 457-474.
3	ZhouH, LiZ, LiangH,et al.Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study[J].Platelets,2021:1-9.
4	DaneseE, MontagnanaM, FavaloroEJ,et al.Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics[J].Semin Thromb Hemost,2020,46 (3):264-274.
5	杨九一, 顾健. 药源性血小板减少症机制研究进展[J]. 中国医院药学杂志, 2013, 33 (22) : 1874-1877.
6	BakchoulT, MariniI.Drug-associated thrombocytopenia[J].Hematology Am Soc Hematol Educ Program,2018 (1):576-583.
7	GeorgeJN, AsterRH.Drug-induced thrombocytopenia: pathogenesis, evaluation, and management[J].Hematology Am Soc Hematol Educ Program,2009:153-158.
8	VoQT, ThompsonDF.A review and assessment of drug-induced thrombocytosis[J].Ann Pharmacother,2019,53 (5):523-536.
9	AlzahraniM, AlrumaihI, AlhamadF,et al.Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature[J].Platelets,2018,29 (6):628-631.

No related articles found!

阅读次数

全文

摘要